5-{2-Fluoro-4-[2-(2-fluoro-benzyl)-3-oxo-cyclohex-1-enylamino]-phenyl}-4,4-dimethyl-2,4-dihydro-pyrazol-3-one

ID: ALA131672

PubChem CID: 23647054

Max Phase: Preclinical

Molecular Formula: C24H23F2N3O2

Molecular Weight: 423.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C)C(=O)NN=C1c1ccc(NC2=C(Cc3ccccc3F)C(=O)CCC2)cc1F

Standard InChI:  InChI=1S/C24H23F2N3O2/c1-24(2)22(28-29-23(24)31)16-11-10-15(13-19(16)26)27-20-8-5-9-21(30)17(20)12-14-6-3-4-7-18(14)25/h3-4,6-7,10-11,13,27H,5,8-9,12H2,1-2H3,(H,29,31)

Standard InChI Key:  VDLINFRONRFGGR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    4.0542   -2.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4167   -3.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7417   -3.3000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7667    1.7083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0542   -2.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5167   -4.0917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7042   -4.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7667    0.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0542    2.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7750   -1.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0542    0.4625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4792    2.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7750   -0.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3417   -1.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0542    2.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0542   -0.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2625   -4.8292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3417    3.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4875    2.8125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917   -2.0250    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3417   -0.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7042   -3.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9917   -2.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6292    2.9375    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4792    0.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2000    1.7083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2000    0.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7750    3.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3417    4.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7792    4.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0625    4.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  2  0
  4  8  2  0
  5  1  1  0
  6  3  1  0
  7  2  1  0
  8 11  1  0
  9  4  1  0
 10  5  2  0
 11 16  1  0
 12  4  1  0
 13 10  1  0
 14  5  1  0
 15  9  1  0
 16 21  1  0
 17  7  2  0
 18 15  1  0
 19 12  2  0
 20 10  1  0
 21 14  2  0
 22  2  1  0
 23  2  1  0
 24 18  1  0
 25  8  1  0
 26 27  1  0
 27 25  1  0
 28 15  2  0
 29 18  2  0
 30 28  1  0
 31 30  2  0
  6  7  1  0
 16 13  2  0
 26 12  1  0
 31 29  1  0
M  END

Associated Targets(Human)

PDE3B Tclin Phosphodiesterase 3B (312 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 423.46Molecular Weight (Monoisotopic): 423.1758AlogP: 4.49#Rotatable Bonds: 5
Polar Surface Area: 70.56Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.64CX Basic pKa: 1.68CX LogP: 4.55CX LogD: 4.55
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.74Np Likeness Score: -0.63

References

1. Edmondson SD, Mastracchio A, He J, Chung CC, Forrest MJ, Hofsess S, MacIntyre E, Metzger J, O'Connor N, Patel K, Tong X, Tota MR, Van der Ploeg LH, Varnerin JP, Fisher MH, Wyvratt MJ, Weber AE, Parmee ER..  (2003)  Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors.,  13  (22): [PMID:14592490] [10.1016/j.bmcl.2003.08.056]

Source